Enteric alpha-synuclein expression is increased in Crohn’s disease
暂无分享,去创建一个
M. Neunlist | A. Prigent | P. Derkinderen | A. Bourreille | M. Rolli-Derkinderen | G. Chapelet | A. Lionnet | Emilie Durieu
[1] M. Dubinsky,et al. Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease , 2018, JAMA neurology.
[2] B. Pakkenberg,et al. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 , 2018, Gut.
[3] U. Dillmann,et al. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease. , 2018, Parkinsonism & related disorders.
[4] M. Neunlist,et al. Crohn’s and Parkinson disease: is LRRK2 lurking around the corner? , 2018, Nature Reviews Gastroenterology & Hepatology.
[5] G. Wong,et al. A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity , 2017, Journal of Innate Immunity.
[6] D. Devos,et al. Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.
[7] S. Landas,et al. Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease , 2012, Inflammatory bowel diseases.